Skip to main content

Table 4 Comparisons of the serum adiponectin (ng/mL) between genders in the four groups

From: Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control study

Group

P-value

Gender

adiponectin (ng/mL)

   

median (p25-p75)

JO

0.512

male

1742.3(1347.9–2171.5)

 

female

2096.1(1526.9–2868.6)

OH

0.009**

male

1734(1384.3–2284.2)

 

female

2857.6(2298.5–3875.4)

JH

0.877

male

1866.5(1537.9–2915.3)

 

female

1643.5(1184.6–4213.5)

NH

0.001**

male

1961.6(1593.5–2366.1)

 

female

2943.7(2716.6–3938.4)

  1. **: p < 0.01 (highly significant);NH, normal healthy group; JH, newly;diagnosed untreated just-hypertension group; JO, newly diagnosed untreated;just-obesity group; OH, newly diagnosed untreated obesity-hypertension group